FITB
60
4
AMZN
64
4
MA
71
2
GOOGL
56
2
AIG
53
3
JNJ
50
3
TROW
40
14
MRK
48
2
NRG
62
-13
WFC
77
3
HRB
55
3
GPC
41
-3
STX
87
10
KSS
37
3
NWS
54
-6
FTI
64
3
AXP
73
4
DVN
29
2
TXT
70
2
NSC
67
2
FITB
60
4
AMZN
64
4
MA
71
2
GOOGL
56
2
AIG
53
3
JNJ
50
3
TROW
40
14
MRK
48
2
NRG
62
-13
WFC
77
3
HRB
55
3
GPC
41
-3
STX
87
10
KSS
37
3
NWS
54
-6
FTI
64
3
AXP
73
4
DVN
29
2
TXT
70
2
NSC
67
2
Financhill
Back

CytoSorbents 10K Form

Buy
61

CTSO
CytoSorbents

Last Price:
$1.05
Seasonality Move:
-2.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-09 10Q CTSO/CytoSorbents Quarterly
2023-08-01 10Q CTSO/CytoSorbents Quarterly
2023-05-02 10Q CTSO/CytoSorbents Quarterly
2022-11-03 10Q CTSO/CytoSorbents Quarterly
2022-08-02 10Q CTSO/CytoSorbents Quarterly
2022-05-03 10Q CTSO/CytoSorbents Quarterly

Receive CTSO News And Ratings

See the #1 stock for the next 7 days that we like better than CTSO

CTSO Financial Statistics

Sales & Book Value

Annual Sales: $35.6M
Cash Flow: $-3.5M
Price / Cash Flow: 0
Annual Sales: $0.23
Price / Book: 4.56

Profitability

EPS (TTM): -0.27940
Net Income (TTM): $-15.8M
Gross Margin: $25.1M
Return on Equity: -106.57%
Return on Assets: -32.14%

CytoSorbents Earnings Forecast

Key CytoSorbents Financial Ratios

  • The Gross Profit Margin over the past 17 years for CTSO is 70.59%.
  • The Selling, General & Administrative Expenses for CTSO have been equal to 98.32% of Gross Profit Margin.
  • The Research & Development expenses have been 19.43% of Revenue.
  • The Net Earning history of CTSO is -58.21% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 10 years.

CytoSorbents Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: CTSO
CUSIP: 23283X
Website: cytosorbents.com

Debt

Debt-to-Equity Ratio: 0.98
Current Ratio: 2.61
Quick Ratio: 1.98

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 46.83

CTSO Technical Analysis vs Fundamental Analysis

Buy
61
CytoSorbents (CTSO) is a Buy

Is CytoSorbents a Buy or a Sell?

  • CytoSorbents stock is rated a Buy
    The current CytoSorbents [CTSO] share price is $1.06. The Score for CTSO is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.